SCHEMBL3394561

SCHEMBL3394561

COCOc1cc(C=O)ccc1OC

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 12/20 0.70
TSHR P16473 1/20 0.70
FDPS P14324 1/20 0.65
MAPT P10636 5/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
HTT P42858 2/20 0.60
LMNA P02545 1/20 0.60
NPSR1 Q6W5P4 1/20 0.60
HPGD P15428 4/20 0.54
AOX1 Q06278 1/20 0.54
TRIM24 O15164 1/20 0.54
ALDH5A1 P51649 1/20 0.54
ABAT P80404 1/20 0.54
TDP1 Q9NUW8 1/20 0.54
TRIM33 Q9UPN9 1/20 0.54
PDCD1 Q15116 1/20 0.52
CD274 Q9NZQ7 1/20 0.52
TTR P02766 1/20 0.51
NPC1 O15118 1/20 0.50
RAB9A P51151 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2850023 0.93 FDPS (0.75) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL31054299 0.93 FDPS (0.75) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL31160627 0.93 FDPS (0.64) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL4255761 0.93 FDPS (0.64) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL28645184 0.87 ALDH1A1 (0.62) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL2679839 0.87 ALDH1A1 (0.62) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL7661907 0.86 FDPS (0.86) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL1515797 0.85 FDPS (0.78) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL5974454 0.84 FDPS (0.77) ALDH1A1TSHRFDPSMAPTSMN1; SMN2
SCHEMBL30416638 0.84 ALDH1A1 (0.72) ALDH1A1TSHRFDPSMAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4630413-A1 FLAVANONE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS Firmenich Incorporated (US) 2025-10-15 EP disclosed
US-20250134146-A1 FLAVANONE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS FIRMENICH INCORPORATED (US) 2025-05-01 US disclosed
CN-119504685-A Benzopyran flavonoid compound, preparation method and application thereof, and pharmaceutical preparation 南开大学 2025-02-25 CN disclosed
CN-116375571-B Xanthohumol derivative and application thereof 中国人民解放军海军军医大学 2024-12-24 CN disclosed
CN-118829632-A Flavanone compounds and their use as flavor modifiers 弗门尼舍公司 2024-10-22 CN disclosed
WO-2024177901-A1 FLAVANONE COMPOUNDS AND THEIR USE AS FLAVOR MODIFIERS FIRMENICH INCORPORATED (US) 2024-08-29 WO disclosed
CN-116375571-A Xanthohumol derivative and application thereof 中国人民解放军海军军医大学 2023-07-04 CN disclosed
US-9394268-B2 (E)-1-(5-methoxy-2,2-dimethyl-2H-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one and analogs thereof, as well as preparation method and use thereof SICHUAN UNIVERSITY (CN) 2016-07-19 US disclosed
US-9394268-B2 (E)-1-(5-methoxy-2,2-dimethyl-2H-chromen-8-yl)-3-(4-methoxyphenyl)prop-2-en-1-one and analogs thereof, as well as preparation method and use thereof SICHUAN UNIVERSITY (CN) 2016-07-19 US disclosed
EP-2984077-A1 COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE Chromocell Corporation (US) 2016-02-17 EP disclosed
EP-1386913-A1 PYRROLE DERIVATIVE SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) 2004-02-04 EP disclosed
US-6407229-B1 ENZYME INHIBITOR SANOCHEMIA PHARMAZEUTIKA AG (AT) 2002-06-18 US disclosed
US-6369238-B1 ENZYME INHIBITORS USED IN THE TREATMENT OF ALZHEIMER'S DISEASE SANOCHEMIA PHARMAZEUTICA (AT) 2002-04-09 US disclosed
US-6043359-A REACTING A BENZALDEHYDE DERIVATIVE WITH A BENZENE ETHYLAMINE DERIVATIVE TO FORM A SCHIFF BASE, REDUCING THE SCHIFF BASE TO PRODUCE AN INTERMEDIATE, OXIDATIVELY CYCLYZATION, THEN STEREOSELECTIVE REDUCTION FORMS END PRODUCT SANOCHEMIA PHARMAZEUTICA AKTIENGESELLSCHAFT (AT) 2000-03-28 US disclosed
EP-0787115-B1 PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE SANOCHEMIA PHARMAZEUTIKA AG (AT) 2000-01-05 EP disclosed
EP-0787115-A1 PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO 3a,3,2-ef] 2]BENZAZEPINE Waldheim Pharmazeutika Gesellschaft m.b.H. (AT) 1997-08-06 EP disclosed
WO-1996012692-A1 PROCESS FOR PRODUCING DERIVATIVES OF 4a,5,9,10,11,12,-HEXAHYDRO-6H-BENZOFURO[3a,3,2-ef][2]BENZAZEPINE WALDHEIM PHARMAZEUTIKA GESELLSCHAFT M.B.H. (AT) 1996-05-02 WO disclosed
US-5234951-A Anti-ulcer agent comprising chalcone derivative TSUMURA JUNTENDO, INC. (JP) 1993-08-10 US disclosed
US-5106871-A Reduced side effects TSUMURA & CO. (JP) 1992-04-21 US disclosed
EP-0292576-A1 ANTI-ULCEROUS AGENT CONTAINING CHALCONE DERIVATIVE AS EFFECTIVE INGREDIENT AND NOVEL CHALCONE DERIVATIVES TSUMURA & CO. (JP) 1988-11-30 EP disclosed